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Abstract
Background: Obesity and periodontitis are important chronic health problems. Obesity is associated with an
increased prevalence of periodontitis. Whether obesity also affects the outcome of non-surgical periodontal therapy
is to date still unclear.
Methods: A systematic review of studies referenced in SCOPUS, MEDLINE, PubMed, Cochrane, CINAHL, Biosis and
Web of Science was performed. Titles, abstracts and finally full texts were scrutinized for possible inclusion by two
independent investigators. Quality and heterogeneity of the studies were assessed and the study designs were
examined. Probing pocket depth reduction was analyzed as primary surrogate parameter for therapeutic success
after non-surgical periodontal therapy.
Results: One-hundred-and-fifty-nine potentially qualifying studies were screened. Eight studies fulfilled the inclusion
criteria and were analyzed. Three of eight studies failed to show an influence of obesity on pocket depth reduction
after non-surgical therapy. The remaining five studies documented a clear negative effect on the outcome of
non-surgical periodontal therapy. The finally included studies did not correspond to the highest level of quality
(RCTs). Due to the heterogeneity of the data a meta-analysis was not possible.
Conclusion: The literature on the effect of obesity on the treatment outcome of non-surgical periodontal therapy
remains controversial. The data, however, support that obesity is not only a factor associated with poorer
periodontal health but might also result in inferior response to non-surgical treatment of periodontitis.
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Background
The prevalence of obesity is increasing worldwide and is
becoming one of the most important health hazards [1],
as obesity is highly associated with increased overall
morbidity and mortality [2].
Obesity is defined with a body mass index (BMI; body
weight in kilogram divided by the square of the height in
meters (kg/m2)) of at least 30.0 kg/m2 [3], whereas over-
weight is defined with a BMI of 25–29.9 kg/m2. Normal
weight is characterized by a BMI ranging between 19 to
24.9 kg/m2 [4]. In this context, BMI seems a valuable
parameter to predict obesity-related disease risks in a
wide range of populations [2]. There are, however, some
limitations: Firstly, risk assessment by BMI is less applic-
able in persons over 65 years of age because they gener-
ally have a higher body fat content for the same BMI.
Secondly, the abdominal (central, visceral, android) type
of obesity, which is more often seen in men, is associ-
ated with higher morbidity than the rather female type
of gluteofemoral (peripheral, gynoid) obesity and, thirdly,
the BMI cut-off points for overweight and obesity are
too high for Asian people [2]. In addition, current large
studies have indicated that measurement of waist cir-
cumference (WC) or waist-to-hip-ratio (WHR) may be a
better disease risk predictor than BMI [5, 6]. There is,
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however, currently intensive research and debate as to
whether BMI, WC, WHR, or all of them should be used
to assess disease risk [2].
For the purpose of this systematic review, however,
only BMI is the most frequently reported data of obesity
in a large number of studies.
Adipose tissue contains usually 5-10 % macrophages,
but the adipose tissue of obese patients shows up to
60 % macrophage infiltration [4]. Adipocytes secrete bio-
active molecules called adipokines, that can modify or
trigger inflammation and fat metabolism locally or sys-
temically as signaling molecules to liver, muscle and
endothelium [4]. Therefore, the adipose tissue can be
considered as an important metabolically active endo-
crine organ [4].
This explains how obesity acts as a risk factor for
several chronic diseases: Hypertension, type 2 diabetes,
dyslipidemia, and coronary heart disease are so closely
related to obesity that obesity itself is often considered
to be a systemic disease. This disease also affects dental
health [7]. Accordingly obese persons require attention
of physicians and dentists [2].
Among dental pathologies, periodontitis is a very com-
mon, primarily bacterial inflammatory disease, which de-
stroys teeth surrounding soft tissues and bone. It leads
to pocket formation and ultimately to loss of teeth if no
effective treatment is applied [8]. Periodontitis is no lon-
ger considered only an oral health issue but also a public
health problem, as it constitutes a risk factor for cardio-
vascular conditions, poor glycemic control in diabetics
and adverse outcome of pregnancy [4, 8]. These correla-
tions coincide with obesity and general health.
Recently, it has been suggested that obesity is a pos-
sible risk factor for periodontitis [8]. One study identi-
fied obesity even as the second strongest risk factor for
periodontitis preceded only by smoking [9]. The first re-
port on the relationship between obesity and periodontal
disease appeared in 1977. Perlstein and co-workers [10]
found greater alveolar bone resorption in obese than in
non-obese rats. Under healthy oral conditions, obesity it-
self did not promote periodontal damage, but in the
presence of bacterial plaque accumulation periodontal
inflammation was more severe in obese than in non-
obese animals. With concomitant arterial hypertension,
plaque accumulation caused even more pronounced
periodontal destruction than with obesity alone. These
results suggest that a combination of risk factors, such
as the one defined by the metabolic syndrome, elicit a
more severe periodontal effect [10, 11]. Chaffee et al.
[12] found in their meta-analysis an increased prevalence
odds ratio for obesity among subjects with periodontal
disease of approximately one-third, a greater mean clin-
ical attachment loss (CAL) among obese individuals, a
higher BMI among subjects with periodontal disease,
and a trend for linear increase in the odds of periodontal
disease with increasing BMI [4, 12]. Finally the associ-
ation reported between obesity and periodontitis was
less strong than that reported between periodontal dis-
ease and adverse pregnancy outcomes [12, 13] or cardio-
vascular events [12, 14]. There seems, however, to be a
stronger obesity-periodontitis association in women,
non-smokers and younger individuals than in the gen-
eral adult populations [12]. In addition, smoking remains
another well-studied predisposing factor for periodon-
titis [12, 15, 16]. Thus, BMI and smoking share a com-
plex relationship [17]. This relationship can be inverse in
certain populations [12, 18, 19].
The biological mechanism by which obesity predis-
poses to periodontitis is not fully understood [8]. Com-
pared to individuals with normal weight individuals with
obesity have higher levels of circulating tumor necrosis
factor-α (TNF-α) and interleukin-6 (IL-6), which are also
secreted from adipose tissue and are involved in the
pathophysiology of both obesity and periodontitis. Not
surprisingly, serum levels of these cytokines decrease
with loss of weight [20].
The objective of this systematic review was to study
the hypothesis whether the clinical outcome, in terms of
pocket depth reduction, after non-surgical periodontal
therapy in non-obese is better than in obese individuals.
To verify this hypothesis, we systematically reviewed all
retrievable, qualitatively adequate clinical investigations,
which focused on this topic.
Methods
The review was conducted according to the PRISMA
criteria [21]. The research question was explored using
the PICO method [22). The focused question addressed
was:
Does non-surgical periodontal therapy (I) have a dif-
ferent outcome in obese chronic periodontitis patients
(P), than in non-obese chronic periodontitis patients (C),
regarding periodontal pocket depth reduction as the
main clinical periodontal parameter (O).
Search strategy and review process
An electronic search of SCOPUS, MEDLINE, PubMed,
Cochrane, CINAHL, Biosis and Web of Science was car-
ried out considering articles published up to January 2016
in English or German language. The search was per-
formed in two steps. The first electronic search started at
20.11.14 and an update has been done at 5.1.16.
This is shown in Table 1. For the database search, a
combination of subject headings (MeSH terms and
CINAHL headings) and free text search was used. An
example of a detailed strategy (Medline/OvidSP) is
shown in Table 2.
The same search protocol was applied to all databases.
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Two of the authors (FAG, PRS) screened the titles for
potential eligibility according to the inclusion criteria.
Based on the abstract screening, 18 studies were selected
for full text review. Scores were independently allocated
by both authors to each publication according to their
suitability for the present review (see inclusion criteria).
Any discrepancies were resolved by consensus.
Inclusion criteria
To be included studies had to be clinical interventional
studies regarding the outcome of non-surgical periodontal
therapy in obese or non-obese patients. The studies had
to display the diagnosis of chronic periodontitis. Key pa-
rameters to be reported were data for pocket probing
depth (PPD) and BMI.
Exclusion criteria
Studies were excluded for the following reasons: animal
studies, case reports, commentaries, unsuitable exposure
or outcome measures, confounding medical diagnoses
(e.g. pregnancy or any systemic disease, such as diabetes,
in addition to metabolic syndrome), confounding sys-
temic medical treatments such as immunosuppressive
treatments, cortisone or antibiotic treatment as well as
confounding local treatments such as treatment of peri-
mucositis, gingival overgrowth or surgical periodontal
treatment. Studies including either the diagnosis of
aggressive periodontitis or of peri-implantitis were
excluded as well.
Outcome measures
The primary outcome measure is PPD after non-surgical
periodontal treatment.
Data extraction
A list with exclusion reasons for each paper was gener-
ated. Total number of patients, demographic data, origin
of study, outcome measurements 2, 3, 6 and 12 months
after therapy and the impact of obesity on the treatment-
outcome were extracted. In addition, the exact definition
of chronic periodontitis, the assessment of the periodontal
disease and the number of smokers included in the studies
were summarized. Data on the individual definition of obes-
ity and the systemic examinations were also collected. Non-
surgical periodontal treatment measures, treatment time,
periodontal maintenance and adverse events were also
recorded for each study separately (Tables 3, 4, 5, 6 and 7).
The quality of the included studies was assessed
through the Newcastle-Ottawa Quality Assessment Scale
(Table 8).
Results
Selection of studies
Initially, 159 studies were identified by electronic search
by the two reviewers (FAG, PRS). Full text analysis of the
18 potentially qualified reports led to exclusion of 10 other
studies. Additional five titles [23–27] were identified by
hand search but after full text analysis, all these articles
had to be excluded based on the inclusion and exclusion
Table 1 Search protocols with the respective number of
references dated from November 11 2014 (1) and January 1
2016 (2)
References 1 & 2 References after deduplication 1 & 2
Scopus 40 + 14 9 + 5
Medline 42 + 8 39 + 7
PubMed 6 + 11 2 + 11
Cochrane 12 + 2 2 + 1
CINAHL 48 + 15 42 + 13
Biosis 25 + 7 10 + 1
Web of Science 38 + 13 16 + 1
Pool 211 + 70 120 + 39
After deduplication 159 references
Table 2 Medline search strategy
Step Query Hits
1 Exp Periodontitis/AND (adult OR chronic*).ti,ab. 5703
2 Chronic periodontitis/OR periodontal pocket/ 7004
3 2 OR 3 10454
4 ((adult OR chronic*) adj3 periodontiti*).ti,ab. 5352
5 (attachment adj3 loss).ti,ab. AND ((clinical OR
periodontal) adj3 attachment).ti,ab.
1305
6 (periodontal adj3 pocket).ti,ab. 1066
7 OR/3-7 12910
8 Dental scaling/ OR “root planing”/ 3479
9 ((subgingival OR root OR supragingival) adj3
(scaling* OR planing*)).ti,ab.
2288
10 (deep adj3 (scaling* OR cleaning)).ti,ab. 62
11 ((conventional OR inital OR “non surgical” OR
non-surgical OR nonsurgical) adj3
(treatment OR therapy)).ti,ab.
33417
12 OR/8-11 37131
13 7 AND 12 2184
14 Exp Obesity/ 154540
15 Exp Body Weight/ 369850
16 (overweight OR obese OR obesity OR adiposit*
OR BMI OR “body mass index”).ti,ab.
300847
17 (cardiolipin OR lipid* OR leptin).ti,ab. 395517
18 “waist to hip”.ti,ab. 9048
19 (body adj3 weight).ti,ab. 163760
20 OR/14-19 954233
21 13 AND 20 42
The asterisk represents a wildcard and can be used in all search fields that
allow words and phrases
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Table 3 Excluded studies
Excluded studies Reason for exclusion
Europerio 4 2003 [37) Not addressing research
question
Abstracts for the Royal Australian and
New Zealand College of Psychiatrists 2005
[38]
Not addressing research
question
5th Joint Meeting of the European Tissue
Repair Society and the Wound Healing
Society 2009 [39]
Not addressing research
question
Recently published abstracts [40] Not addressing research
question
DENTSPLY Posters 2012 [41] Not addressing research
question
HealthBeat 2007 [42] Not addressing research
question
Abstracts for Poster Presentations 2011
[43]
Not addressing research
question
Abstracts for the International Symposium
on Dental Hygiene 2013 [44]
Not addressing research
question
Abou Sulaiman et al. 2010 [45] Not addressing research
question
Acharya et al. 2010 [46] No PPD reduction data
Akpinar et al. 2013 [47] Not addressing research
question
Altay et al. 2013 [20] No PPD reduction data
Armstrong et al. 2010 [48] Not addressing research
question
Arora et al. 2013 [49] Not addressing research
question
Basegmez et al. 2011 [50] Not addressing research
question
Bresolin et al. 2013 [51] Not addressing research
question
Bresolin et al. 2014 [52] Not addressing research
question
Caspersen et al. 2012 [53] Not addressing research
question
Caula et al. 2014 [54] No comparison
Caula et al. 2014 [54] Duplicate
Chapple et a. 2006 [55] Not addressing research
question
Chapple et al. 2007 [56] Not addressing research
question
Chandni et al. 2015 [57] Not addressing research
question
Chaston et al. 2014 [58] Not addressing research
question
Chee et al. 2008 [59] Inclusion of diabetes
Chee et al. 2013 [60] Missed intervention,
inclusion of diabetes
Chen et al. 2012 [61] Inclusion of diabetes
D’Aiuto et al. 2004 [62] Not addressing research
question
Table 3 Excluded studies (Continued)
D’Aiuto et al. 2004 [63] Not addressing research
question
D’Aiuto et al. 2005 [23] No comparison
D’Aiuto et al. 2006 [64] Not addressing research
question
Deppe et al. 2010 [65] Not addressing research
question
Dodington et al. 2015 [66] No obesity data
Draper et al. 2010 [67] Not addressing research
question
Duan et al. 2009 [24] Written in Chinese
Edwards et al. 2006 [68] Not addressing research
question
Efurd et al. 2012 [69] Not addressing research
question
Elliott-Smith et al. 2011 [70] Not addressing research
question
Engebretson et al. 2014 [71] Not addressing research
question
Fairfield et al. 2010 [72] Not addressing research
question
Fang et al. 2015 [73] Inclusion of end-stage renal
disease patients
Fentoglu et al. 2010 [74] Statin intake
Fine et al. 2007 [75] Not addressing research
question
Fokkema et al. 2012 [76] Not addressing research
question
Fu et al. 2015 [77] No comparison
Garcia et al. 2010 [78] Not addressing research
question
Giblin et al. 2014 [79] Inclusion of prediabetes
Giblin et al. 2014 [79] Duplicate
Gluch et al. 2007 [80] Inclusion of diabetes
Goldie et al. 2002 [81] Not addressing research
question
Goldie et al. 2004 [82] Not addressing research
question
Goldie et al. 2005 [83) Not addressing research
question
Griffin et al. 2012 [84] Not addressing research
question
Gurenlian et al. 2006 [85] Not addressing research
question
Gurenlian et al. 2009 [86] Not addressing research
question
Hammaker et al. 2010 [87] Not addressing research
question
Horwitz et al. 2007 [88] Not addressing research
question
Hovliaras-Delozier et al. 2008 [89] Not addressing research
question
Ide et al. 2004 [90] No obesity data
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Table 3 Excluded studies (Continued)
Ide et al. 2007 [91] Not addressing research
question
Iwamoto et al. 2003 [25] Application of antibiotics
Jahn et al. 2004 [92] Not addressing research
question
Jahn et al. 2015 [93] Not addressing research
question
Jaiswal et al. 2015 [94] No treatment (SRP)
Janket et al. 2014 [95] Meta-analysis
Janket et al. 2014 [95] Duplicate
Jared et al. 2008 [96] Not addressing research
question
Jared et al. 2008 [96] Duplicate
Jiang et al. 2013 [97] Not addressing research
question
Kamil et al. 2011 [98] No obesity data
Kamilov et al. 1998 [99] Not addressing research
question
Kapellas et al. 2013 [100] No obesity data
Kardeşler et al. 2010 [26] Inclusion of diabetes
Keller et al. 2015 [101] Systematic review
Kiany et al. 2014 [102] No obesity data
Kiany et al. 2015 [103] Duplicate
Kipp et al. 2003 [104] Not addressing research
question
Kudva et al. 2010 [105] Inclusion of diabetes
Kumar et al. 2015 [106] Inclusion of diabetes
Kurti et al. 2007 [107] Not addressing research
question
Kurtis et al. 2007 [108] Duplicate
Lee et al. 2014 [109] Not addressing research
question
Li et al. 2013 [110] No obesity data
Ling et al. 2012 [111] Inclusion of diabetes
Lo et al. 2011 [112] Not addressing research
question
Malhotra et al. 2012 [113] No obesity data
Mancl et al. 2013 [114] Not addressing research
question
Martinez et al. 2014 [115] Supplementation of ω-3
eicosapetaenoic acid
Martinez et al. 2014 [116] One year of omega-3
supplementation
Matlock et al. 2012 [117] No treatment (SRP)
McDaniel et al. 2013 [118] Not addressing research
question
Meharwade et al. 2014 [119] Local drug delivery
Merchant et al. 2014 [120] Inclusion of diabetes
Michalowicz et al. 2014 [121] Inclusion of diabetes
Table 3 Excluded studies (Continued)
Mizrak et al. 2006 [122] Not addressing research
question
Moeintaghavi et al. 2012 [123] Inclusion of diabetes
Moravec et al. 2011 [124] No treatment (SRP)
Muthu et al. 2015 [125] No obesity data
Nassar et al. 2012 [126] Inclusion of diabetes
Newton et al. 2011 [127] Not addressing research
question
Nichols et al. 2001 [128] Not addressing research
question
Nielsen et al. 2000 [129] Not addressing research
question
Novakovic et al. 2013 [130] Not addressing research
question
Novakovic et al. 2014 [131] Not addressing research
question
Oliveira et al. 2011 [132] Not addressing research
question
Olsen et al. 2006 [133] Not addressing research
question
Paquette et al. 2008 [134] Not addressing research
question
Perayil et al. 2014 [135] No obesity data
Perayil et al. 2014 [136] Duplicate
Phillips et al. 2013 [137] Not addressing research
question
Pradeep et al. 2007 [138] Not addressing research
question
Price et al. 2010 [139] Not addressing research
question
Qiqiang et al. 2012 [140] No obesity data
Radafshar et al. 2012 [141] Not addressing research
question
Radnai et al. 2009 [142] Not addressing research
question
Raghavendra et al. 2012 [143] Not addressing research
question
Ramirez et al. 2011 [144] No obesity data
Rasch et al. 1995 [145] Not addressing research
question
Sadatmansouri et al. 2006 [146] Not addressing research
question
Saffi et al. 2013 [147] Inclusion of patients with
coronary disease
Saffi et al. 2013 [147] Duplicate
Saffi et al. 2014 [148] Inclusion of patients with
coronary artery disease
Shruti et al. 2010 [27] No obesity data
Sembene et al. 2000 [149] Not addressing research
question
Sengupta et al. 1990 [150] Not addressing research
question
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criteria (Table 3). Therefore, eight publications [8, 28–
34] from the electronic and hand search fulfilled the cri-
teria. However, it was not possible to compare the raw
data so that we had to reduce our analysis to a qualita-
tive analysis. This process is summarized in a flow-chart
(Fig. 1).
Summary of studies: characteristics (PICO)
Total number of patients, demographic data, origin of
study, outcome measurements 2, 3, 6 and 12 months
after therapy and the impact of obesity on the treatment-
outcome are summarized in Table 4.
Definition of chronic periodontitis, periodontal assess-
ment and the amount of smokers included are depicted
in Table 5.
The definition of obesity and systemic examination
were summarized in Table 6. Non-surgical periodontal
treatment, treatment time, periodontal maintenance and
limitations are shown in Table 7.
Population
Of the eight finally analyzed studies, clinical trials com-
prised 516 participants. One study [8] enrolled only
women. The prevalence of smoking among male patients
affected with periodontitis was so high that Al-Zahrani
and co-workers [8] were unable to correct for smoking
in the male population. Accordingly, only women were
included in their study. Overall the studies comprised
between 26 up to 260 subjects (Table 4).
The inclusion criteria “age” was defined in all but one
study [30]. Three investigations [28, 33, 34] defined the
age ≥18 years. The other studies defined a minimum age
of 30 years [31, 32] or 35 years [8]. Duzagac et al. de-
fined an age range from 25 to 55 years (Table 4).
Suvan et al. [34] included smokers into their study.
Lakkis et al. [33] and Eldin et al.(30] did not mention
the smoking status of the patients. All other studies [8,
28, 29, 31, 32] excluded smokers (Table 5).
Patients with diabetes, another important modifier of
periodontal health or disease [35] were excluded in
seven studies [8, 28–32, 34]. Lakkis et al. [33] did not re-
port the presence or absence of diabetes.
Intervention/Comparison
Each paper described the periodontal intervention as a
non–surgical therapy. All studies [8, 28–34] applied scal-
ing and root planing. Ultrasonic instruments and/or
hand instruments were used in all studies (Table 7).
Two papers (8,34] reassessed the PPD 2 months after
therapy. Two studies [29, 30] reassessed their patients
after 3 months. Another two papers [28, 31] re-
evaluated the patients after 3 and 6 months and one
study [32] reassessed the PPD three, six and 12 months
after therapy. Only Lakkis et al. [33] measured the peri-
odontal pocket depths already 4 to 6 weeks after non-
surgical therapy (Table 3). Oral hygiene was instructed
additionally to the non–surgical periodontal therapy in
all studies (Table 7).
Due to the heterogeneity of the study designs with re-
spect to outcome measures and treatment protocol, as
well as variation in study population, sample size, and/or
Table 3 Excluded studies (Continued)
Sgolastra et al. 2013 [36] Meta-Analysis
Shimada et al. 2010 [151] No comparison
Shimoe et al. 2011 [152] Case report
Singh et al. 2014 [153] Not addressing research
question
Siqueira et al. 2013 [154] Not addressing research
question
Stewart et al. 2001 [155] Inclusion of diabetes
Talbert et al. 2006 [156] Inclusion of diabetes
Tamaki et al. 2009 [157] No obesity data
Tamaki et al. 2011 [158] No obesity data
Tawfig et al. 2015 [159] No comparison
Teles et al. 2012 [160] No comparison
Toker et al. 2012 [161] Not addressing research
question
Tuter et al. 2007 [162] Inclusion of patients with
systemic disease
Vardar et al. 2003 [163] Not addressing research
question
Van Dyke et al. 2015 [164] Not addressing research
question
Vyas et al. 2000 [165] Not addressing research
question
Wahid et al. 2013 [166] Not addressing research
question
Wang et al. 2013 [167] Inclusion of aggressive
periodontitis
Wehmeyer et al. 2013 [168] Not addressing research
question
Wei et al. 2010 [169] No obesity data
Williams et al. 2007 [148] No obesity data
Williams et al. 2009 [170] Not addressing research
question
Williams et al. 2009 (171] Not addressing research
question
Wood et al. 2006 [172) Not addressing research
question
Wu et al. 2015 [173) Not addressing research
question
Zare et al. 2014 [174) Not addressing research
question
Zhou et al. 2013 [175] Inclusion of patients with
systemic disease
Zuza et al. 2011 [176) No PPD reduction data
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Table 4 Probing pocket depth (PPD [mm]) as primary outcome variable
Author & year Total number of patients
Age (mean ± SD)
Country
Outcome after 2 months
mean (± SD) at baseline –
mean (± SD) at reassessment
Outcome after 3
months
mean (± SD)
at baseline –
mean (± SD)
at reassessment
Outcome after 6 months
mean (± SD)at baseline –
mean (± SD) at
reassessment
Outcome after
12 months
mean (± SD)at
baseline – mean
(± SD) at
reassessment
Impact of obesity on the treatment -
outcome
mean – reduction of
PPD (± SD)
Al – Zahrani
et al. 2012 [8]
Total number of patients:
40 (only women)
Normal-weight: 20
Obese: 20
Age:
Normal-weight: 43.4 (±7.8)
Obese: 44 (±8.4)
Country:
Saudi Arabia
Total sample:
2.65 (±0.47) – 2.44 (±0.41)
p-value = 0.001
n.r. n.r. n.r. Normal-weight:
0.19 (±0.27)
Obese:
0.23 (±0.33)
p-value = 0.663 (n. sig.)
Bouaziz et al.
2015 [28]
Total number of patients:
36
Normal-weight: 18
Obese: 18
Age:
Range from 22 to 78
Normal-weight: 51.00 (±13.1)
Obese: 51.3 (±16.7)
p-value: n. sig.
Country:
France
n.r. Normal-weight: 3.33
(±0.92) – 2.71 (±0.40)
p-value: n. sig.
Obese: 3.22 (±0.76) –
2.78 (±0.55)
p-value: n. sig.
Normal-weight: 3.33
(±0.92) 2.45 (±0.53)
p-value < 0.05
Obese: 3.22 (±0.76) –
2.43 (±0.49)
p-value < 0.05
n.r. Summary of Multivariable Analysis
Results (Coefficient, 95 % Cl):
△ %PD > 5mm after 3 months to obese
(Model 2):
p-value = 0.02
△ %PD > 5mm after 6 months to obese
(Model 2):
p-value = 0.005
Nb △PD > 2mm after 3 months to Obese
(Model 2);
p-value = 0.02
Nb △PD > 2mm after 6 months to Obese
(Model 2);
p-value = 0.06 (n.sig.)
Duzagac et al.
2015 [29]
Total number of patients:
45
Normal weight patients with
periodontitis (CPNW): 15
Obese patients with periodontitis
(CPO):
15
Normal weight periodontally
healthy control subjects (PHNW): 15
Age:
Range from 28 to 52
CPNW: 41.06 (±7.10)
CPO: 40.66 (±7.98)
PHNW: 39.66 (±6.53)
p-value: n. sig.
Country:
Turkey
n.r. CPNW: 3.19 (±0.38) –
2.51 – (±0.06)
p-value = 0.001
CPO: 4.10 (±0.50) –
2.55 (±0.45)
p-value = 0.001
n.r. n.r. Number of sites
with PD < 4 mm:
Baseline:
CPO: 1706
CPNW: 1766
3 months:
CPO: 2214
CPNW: 2206
% of sites with PD
< 4 mm:
Baseline:
CPO: 75.4
CPNW: 77.9
3 months:
CPO: 97.9
CPNW: 97.3
Similar clinical
healing;
(n. sig.)
Number of sites with
PD ≥ 4 mm:
Baseline:
CPO: 556
CPNW: 502
3 months:
CPO: 48
CPNW: 32
% of sites with PD ≥
4 mm:
Baseline:
CPO: 48
CPNW: 22.1
3 months:
CPO: 2.1
CPNW: 2.7
Similar clinical
healing;
(n. sig.)
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Table 4 Probing pocket depth (PPD [mm]) as primary outcome variable (Continued)
Eldin et al.
2013 [30]
Total number of patients:
26
Overweight: 12
Obese: 14
Age:
Range from 35 to 48
Country:
Egypt
n.r. Overweight: 0.6 (±1.29)
– 0.75 (±2.12)
p-value: n.r.
Obese: 3.15 (±2.43) –
1.59 (±2.34)
p-value: n.r.
n.r. n.r. Overweight:
0.784
Obese:
0.209
p-value = 0.326 (n. sig.)
Gonçalves
et al. 2015 [31]
Total number of patients:
39
Without obesity: 21
With obesity: 18
Age:
Without obesity: 48.4(±9.5)
With obesity: 48.8 (±5.9)
p-value= 0.85 (n. sig.)
Country:
Brazil
n.r. Without obesity: 3.4
(±0.6) – 3.0 (±0.5)
p-value: sig.
With obesity: 3.6 (±0.6)
– 3.3 (±0.6)
p-value: sig.
Without obesity:
3.4 (±0.6)- 2.7 (±0.6)
p-value: sig.
With obesity:
3.6 (±0.6) – 3.0 (±0.5)
p-value: sig.
n.r. Without obesity
Full-mouth sites:
0-3 months: 0.44
(±0.06)
0-6 months: 0.73
(±0.07)
Initially moderate
sites
(PD 4-6mm):
0-3 months: 0.87
(±0.12)
0-6 months: 1.38
(±0.14)
Initially deep sites
(PD ≥ 7mm):
0-3 months: 1.86
(±0.25)
0-6 months: 3.00
(±0.23)
With obesity
Full-mouth
sites:
0-3 months:
0.30 (±0.06)
0-6 months:
0.54 (±0.07)
Initially
moderate
sites
(PD 4-6mm):
0-3 months:
0.70 (±0.13)
0-6 months:
1.10 (±0.15)
Initially deep
sites
(PD ≥ 7mm):
0-3 months:
1.22 (±0.26)
0-6 months:
2.30 (±0.24)
p-value
(<0.05)
0.08
0.04
0.31
0.16
0.07
0.04
Gonçalves
et al. 2015
[32]
Total number of patients:
40
Non-obese: 20
Obese: 20
Age:
Non-obese: 48.5 (±9.3)
Obese: 50.0 (±4.5)
p-value = 0.52 (n. sig.)
Country:
Brazil
n.r. Non-obese: 3.4 (±0.6) –
2.9 (±0.6)
p-value: sig.
Obese: 3.6 (±0.6) – 3.3
(±0.5)
p-value: sig.
Non-obese: 3.4 (±0.6) –
2.7 (±0.6)
p-value: sig.
Obese: 3.6 (±0.6) – 3.0
(±0.5)
p-value: sig.
Non-obese: 3.4
(±0.6) – 2.6 (±0.6)
p-value: sig.
Obese: 3.6
(±0.6) – 2.9 (±0.4)
p-value: sig.
Mean PPD values (± SD):
After 3 months:
Non-obese: 2.9 (±0.6)
Obese: 3.3 (±0.5)
p = 0.25 (n. sig.)
After 6 months:
Non-obese: 2.7 (±0.6)
Obese: 3.0 (±0.5)
p = 0.04
After 12 months:
Non-obese: 2.6 (±0.6)
Obese: 2.9 (±0.4)
p = 0.03
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Table 4 Probing pocket depth (PPD [mm]) as primary outcome variable (Continued)
Lakkis et al.
2011 [33]
Total number of patients:
30
Surgery: 15
Control: 15
Age:
Surgery: 45.6 (±11.1)
Control: 48.5 (±12.0)
p-value = 0.778 (n. sig.)
Country:
USA (Cleveland, Ohio)
4-6 weeks after therapy!
Surgery:
2.6 (±0.6) – 2.2 (±0.5)
p-value < 0.001
Control:
3.1 (±0.8) – 2.8 (±0.7)
p-value < 0.001
n.r. n.r. n.r. Surgery:
0.45
Control:
0.28
p-value = 0.007
Suvan et al.
2014 [34]
Total number of patients:
260
Normal: 112
Overweight: 93
Obese: 55
Age:
Normal: 46.30 (±8.38)
Overweight: 47.27 (±8.93)
Obese: 46.55 (±6.87)
p-value = 0.701 (n. sig.)
Country:
Great Britain (London)
Summary of univariable
GEE Analysis Results
(Coefficient, 95 % Cl):
BMI [kg/m2] to PPD
at 2 months
p-value = 0.055
Overweight to PPD
at 2 months
p-value = 0.372 (n. sig.)
Obese to PPD at 2 months
p-value = 0.064 (n. sig.)
Summary of Multivariable
GEE Analysis Results
(Coefficient, 95 % Cl):
BMI [kg/m2] to PPD
at 2 months
p-value = 0.013
Overweight to PPD
at 2 months
p-value = 0.63 (n. sig.)
Obese to PPD at 2 months
p-value = 0.031
n.r. n.r. n.r. BMI and obesity were sig. associated with
mean PPD after 2 months. (p = 0.055)
Overweight was not sig. associated with
PPD after 2 months (p = 0.372)
BMI had a stat. sig. linear relationship with
mean PPD after 2 months (p = 0.013).
Overweight compared with normal BMI
status did not demonstrate a stat. sig.
association with mean PPD after 2
months (p = 0.63). Obesity compared
with normal BMI status remained a stat.
sig. predictor of mean PPD (p = 0.031) at
2 months in the same multivariable
model.
CI confidence interval, CPNW normal weight patients with periodontitis, CPO obese patients with periodontitis, kg kilogram, m meter, mm millimeter, Nb Δ PD number of improving PD, n.r. not reported, PD probing
depth, PHNW normal weight periodontally healthy control subjects, PPD periodontal pocket depth, p probability, SD standard deviation, (n.) sig. (not) significant, stat. statistically, WHO world health organisation
G
erber
et
al.BM
C
O
ralH
ealth
 (2016) 16:90 
Page
9
of
20
statistical methods, a statistical synthesis of the results of
the included studies was not possible. So the authors de-
cided to analyze the papers on a qualitative way [22]. A
meta-analysis was not possible.
Outcome
Generally obese patients were found to have deeper peri-
odontal pockets at baseline in all studies.
Three [8, 29, 30] of the eight papers [8, 28–34] re-
ported no major negative impact of obesity on response
to periodontal therapy in terms of PPD reduction (mm).
Al-Zahrani et al. [8] assessed the reduction of PPD
(mm) comparing obese with normal–weighted women.
There was no statistically significant effect of obesity on
treatment outcome. Duzagac et al. [29] assessed the clin-
ical response to non-surgical periodontal treatment,
Table 5 Definition of periodontitis, periodontal assessment and definition of smoking
Author & year Definition of chronic periodontitis Periodontal assessment Smokers
Al – Zahrani
et al. 2012 [8]
≥ 20 teeth,
CAL≥ 3 mm at≥ 30 of the sites
(generalized moderate/severe chronic periodontits)
Full-mouth periodontal examination on all teeth
excluding 3rd molars and partially erupted teeth
Smokers excluded
Bouaziz et al.
2015 [28]
≥ 12 teeth,
≥ 30 % of sites with CAL≥ 3 mm
(moderate-to-severe generalized chronic
periodontitis)
Full-mouth clinical measurements included the
following:
1) PI,
2) BOP,
3) PD (mm),
4) CAL (mm),
PI, BOP, PD, and CAL measurements were performed
using a manual periodontal probe at 6 sites per tooth,
PD was defined as the distance from the free gingival
margin to the bottom of the pocket/sulcus, and CAL
was defined as the distance from the cemento-enamel
junction to the bottom of the pocket/sulcus
Non-smoker or
former smoker
since≥ 5 years
Duzagac et al.
2015 [29]
≥ 20 teeth,
PD≥ 4 mm in≥ 30 % of periodontal sites,
BOP in≥ 50 % of periodontal sites,
interproximal CAL > 2 mm in≥ 20 % of periodontal
sites,
radiographic evidence of bone loss, as described
by Armitage [177]
A Williams-type periodontal probe (UNC15, Hu-Friedy,
Chicago, IL, USA) was used for the measurements of
periodontal parameters, including PI (Silness–Löe)
[178], GI (Löe–Silness) [179], BOP, PD and CAL,
all clinical periodontal measurements were performed
at 6 sites per tooth (mesiobuccal, mid-buccal, distobuccal,
mesiolingual, mid-lingual and distolingual),
excluding third molars
Smokers excluded
Eldin et al.
2013 [30]
n.r.
(chronic periodontitis)
Full-mouth,
4 sites per tooth (mesio-buccal, mid-buccal, disto-buccal,
mid-lingual) around each tooth
n.r.
Gonçalves
et al. 2015
[31]
≥ 15 teeth excluding 3rd molars and teeth with
advanced decay indicated for exodontia,
>30 % of the sites with concomitant PD and
CAL ≥4 mm and a minimum of 6 teeth distributed
in the different quadrants presenting at least one site
with PD and CAL≥ 5 mm and BOP at baseline
(generalized chronic periodontitis)
6 sites per tooth on all teeth excluding 3rd molars
(distance between the gingival margin and the bottom
of the sulcus/pocket [mm])
Smokers excluded
Gonçalves
et al. 2015
[32]
≥ 15 teeth excluding 3rd molars and teeth with
advanced decay indicated for exodontia,
>30 % of the sites with concomitant PD and
CAL≥ 4 mm and a minimum of 6 teeth distributed
in the different quadrants presenting at least one site
with PD and CAL≥ 5 mm and BOP at baseline
(generalized chronic periodontitis)
6 sites per tooth (mesio-buccal, mid-buccal, disto-buccal,
mesio-lingual, mid-lingual, disto-lingual) excluding third
molars, with a manual periodontal probe (UNC15,
Hu-Friedy, Chicago, IL, USA)
Current smokers
excluded, smoking
within the past
10 years excluded
Lakkis et al.
2011 [33]
≥ 20 teeth,
mean CAL≥ 2 mm
(chronic periodontitis)
6 sites per tooth n.r.
Suvan et al.
2014 [34]
PD > 5 mm and marginal alveolar bone
loss > 30 % with > 50 % of the teeth affected
(generalized severe periodontitis)
6 sites per tooth on all teeth present Normal-group =
47 % smokers
Overweight-group =
25 % smokers
Obese-group =
15 % smokers
p - value = 0.045
(sig. on p≤ 0.05)
BoP bleeding on probing, CAL clinical attachment level, GI gingival index, mm millimeter, n.r. not reported, p probability, PD probing depth, PI plaque index,
sig. significant
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according to the severity of periodontitis based on prob-
ing depth < 4 mm vs. ≥ 4 mm. Patients with and without
obesity showed similar clinical healing in terms of per-
centage and number of sites with probing depth < 4 mm
and ≥ 4 mm. So they failed to show an effect of obesity
on the treatment outcome dependent on the severity of
the disease. Eldin et al. [30] also found no effect when
comparing an overweight group with an obese group.
The difference between the groups in reduction of PPD
was not significant (Table 4).
Five [28, 31–34] of the eight papers showed a negative ef-
fect of obesity on the healing after non-surgical periodontal
therapy. Bouaziz et al. [28] revealed that normal-weight pa-
tients had a better response to periodontal treatment than
obese patients. This effect was specially observed for
moderate-to-deep pockets. This fact suggests that the more
severe the periodontitis the more pronounced is the nega-
tive effect of obesity on periodontal treatment outcome.
They showed in the multivariate analysis that obesity was
significantly associated with percentage changes of PD >
5 mm and numbers of improving sites (p ≤ 0.05). In the
univariate analysis all periodontal parameters improve more
in patients suffering from more severe periodontitis at base-
line. Other patient characteristics, like age, sex, obesity, and
WHR, were not associated with periodontal parameter
changes. Gonçalves et al. [31] showed that patients with
obesity and chronic periodontitis had a lower PDD reduc-
tion than patients without obesity. The measurement of the
Table 6 Definition of obesity and systemic examination
Author & year Definition of obesity Systemic examination
Al – Zahrani
et al. 2012 [8]
Normal-weight: BMI: 18.5 to < 25 kg/m2
Obese: BMI≥ 30 kg/m2
Weight in kilograms and height in meters were measured;
BMI: (weight/height2 [kg/m2])
Bouaziz et al.
2015 [28]
Normal-weight: BMI≥ 18.5 kg/m2 and≤ 25 kg/m2
Obese: BMI≥ 30 kg/m2
Weight (kg), height (m), waist/hip circumferences (cm)
weight was obtained using a calibrated scale,,
height was measured using a measuring board,
BMI: (weight/height2 [kg/m2]),
waist measurements were taken at the level of the umbilicus (cm)
hip measurements were taken at the greatest circumference with a
measuring tape,
WHR: ratio of waist to hip circumference
Duzagac et al.
2015 [29]
Normal-weight (CPNW): n.r.
Obese (CPO): BMI≥ 30 % and WHR > 0.95 for males
and 0,80 for females
One trained examiner performed all anthropometric measurements:
weight (kg), height (m), waist (cm), hip (cm),
BMI: (weight/height2 [kg/m2]),
WHR: ratio of waist to hip circumference,
anthropometric measurements were repeated before the final follow-up
visit to assess
whether there was any change in BMI or WHR
Eldin et al.
2013 [30]
Overweight: BMI: 25-29.9 kg/m2
Obese: BMI≥ 30 kg/m2
According to the WHO (3)
n.r.
Gonçalves et al.
2015 [31]
Without obesity: BMI 20-29.9 kg/m2 and
WHR < 0.85 for females and < 0.9 for males
With obesity: BMI≥ 30 kg/m2 and < 40 kg/m2 and
WHR≥ 0.85 for females and WHR≥ 0.9 for males
BMI: (weight/height2 [kg/m2])
WHR: ratio of waist to hip circumference
Non-obese: BMI: 20-24.9 kg/m2 and WHR below that
determined for obesity (i.e. WHR < 0.85 for women and
WHR < 0.90 for men) (World Health Organization 2008)
Obese: BMI≥ 30 and < 40 kg/m2 and concomitant
WHR
≥0.85 for women and WHR≥ 0.90 for men.
One trained examiner performed
all anthropometric measurements:
weight (kg), height (m), waist (cm) and
hip circumferences (cm)
BMI: (weight/height2 [kg/m2]),
WHR: ratio of waist to hip circumference,
anthropometric measurements were reassessed at all follow-up visits to
verify that the patients did not change their obese or non-obese status
during the course of the study
Lakkis et al.
2011 [33]
Control: obese (BMI≥ 30 kg/m2)
Did not have the bariatric surgery nor did they lose
weight to serve as a control group
Surgery: obese (BMI≥ 30 kg/m2) and
≥ 40 % loss of their excess weight at≥ 6 months after
bariatric surgery
BMI: (weight/height2 [kg/m2])
Percentage of weight loss after BS
Suvan et al.
2014 [34]
Normal: BMI: 18.5-24.99 kg/m2
Overweight: BMI: 25-29.99 kg/m2
Obese: BMI≥ 30 kg/m2
BMI: (weight/height2 [kg/m2])
Based upon height and weight of the individual measured with a
wall-mounted height measure and mechanical scales
BF body fat, BMI body mass index, BS bariatric surgery, cm centimeter, CPNW normal weight patients with periodontitis, CPO obese patients with periodontitis,
HDL high-density lipoprotein, kg kilogram, m meter, n. r. not reported, WC waist circumference, WHO world health organization, WHR waist-hip-ratio
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Table 7 Non-surgical periodontal treatment, treatment time and limitations
Author & Year Non-surgical periodontal treatment Treatment time;
periodontal maintenance
Limitations
Al – Zahrani
et al. 2012 [8]
Oral hygiene instructions,
SRP performed by one operator
n.r.;
n.r.
n.r.
Bouaziz et al.
2015 [28]
Oral hygiene instructions (brushing
technique: Bass technique, use of
interproximal hygiene devices, CHX
mouthwash (0.12 %) twice a day for
7 days),
SRP under local anesthesia using an
ultrasonic device and manual curets,
aim of each session was to remove
biofilms and calculus of scaled roots,
treatment protocol did not include
antibiotic treatment,
all treatments procedures were performed
by the same periodontist (WB)
2-3 sessions for probing depth (PD) >
5 mm lasting 1 h each within 7 days;
Oral hygiene was controlled at each
appointment,
hygiene instructions were repeated if
needed
at the 3-month examination, reinstruction
of oral hygiene methods was performed if
needed, and residual pockets≥ 4 mm were
systematically scaled and planed
During the study, two patients dropped
out in each group for the following
reasons:
1) two patients migrated;
2) one missed the 3-month examination;
3) one missed the final examination
Duzagac et al.
2015 [29]
Oral hygiene instructions,
all kinds of dental treatments, such as
fillings and adjustment of overhanging
restorations, were completed immediately
after patient enrollment,
SRP using a reduced Gracey curette set
(Gracey, SAS 5-6, SAS 7-8, SAS 11-12,
SAS13- 14, Hu-Friedy) with an ultrasonic
device (Dentsply/Cavitron, SPS, 30 K, TFI
1000, Dentsply, York, PA, USA) under local
anesthesia,
endpoint of treatment: a smooth tooth
surface,
patients received no adjunctive therapy
(local or systemic antibiotics, NSAI, laser,
ozonotherapy and mouth rinses),
an experienced periodontist (EC)
performed all treatment procedures
(SRP, providing oral hygiene instructions
and organizing patient recalls)
SRP in 4 sequential visits with 2 or 3 days
intervals
completed within 12 days,
each appointment lasted 45 min;
all patients received monthly periodontal
maintenance, including oral hygiene
reinforcement, scaling and polishing as
necessary
8 were excluded for several reasons
did not return for 3 months follow-up,
pregnancy,
weight loss
Eldin et al.
2013 [30]
Oral hygiene instructions,
SRP
n.r.;
periodontal maintenance (re-examination)
performed weekly for 3 months after
therapy
n.r.
Gonçalves et al.
2015 [31]
Oral hygiene instructions,
Supragingival plaque and calculus
removal, exodontia, filling overhang
removal and provisional restoration as
necessary,
trained periodontist performed SRP with
manual curets and ultrasonic device under
local anesthesia,
endpoint for each SRP appointment was
“smoothness of the scaled roots.”
4 to 6 appointments lasting ≈ 1 h each,
periodontal therapy was completed in
14 days;
periodontal maintenance at 3 and
6 months after
therapy
3 patients from the group without
obesity and 6 from the group with
obesity did not return for the 3-months
follow-up visit and were excluded.
Author & Year Non-surgical periodontal treatment Treatment time; periodontal maintenance Adverse events
Gonçalves et al.
2015 [32]
Oral hygiene instructions regarding
brushing technique and
use of dental floss,
supragingival plaque and calculus removal,
exodontia, provisional restoration and
filling overhang removal, as necessary,
trained periodontist performed SRP using
manual curettes (Hu-Friedy, Chicago, IL,
USA) and ultrasonic device (Cavitron Select
SPC, Dentsply professional, York, PA, USA),
under local anaesthesia,
without use of local and/or systemic
antimicrobials.
4 to 6 appointments lasting approximately
1 h each, Periodontal therapy completed
within 2 weeks;
All patients received periodontal
maintenance
every 3 months post-therapy
There were no patient and sampled site
dropouts during the course of the study.
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reduction in PPD (mm) at full-mouth sites showed after
3 months a not statistically significant difference (p =
0.08) between the obese group compared to the group
without obesity. However after 6 months there was a
statistically significant difference (p = 0.04). At this time
point, especially deep sites (PPD ≥ 7 mm) showed a
significantly better result in the group without obesity
(p = 0.04). Another study of Gonçalves et al. [32] reported
that patients with obesity had a significantly greater mean
PD (6 months p-value = 0.04, 12 months p value = 0.03)
than patients without obesity at six and 12 months
post-therapy. The data of a study by Suvan et al. [34]
corroborated these findings and showed that obesity was
an independent impact value of poorer periodontal
treatment outcome 2 months after therapy. The extent of
the association between poorer periodontal treatment
and obesity was similar to that of smoking (p = 0.02).
They worked with 260 patients. This secondary analysis
consisted of individuals participating in five clinical
studies of non-surgical periodontal therapy over a 7-
year period. Lakkis et al. [33] selected 30 patients who
were obese; 15 of them had previously undergone bariat-
ric surgery, whereas the other half (n = 15) did not loose
any weight and served as a control group. The bariatric
surgery group reached a statistically significant greater
mean PPD reduction (0.45 mm versus 0.28 mm) com-
pared with the control (no surgery) group (p = 0.007;
Table 4).
Table 7 Non-surgical periodontal treatment, treatment time and limitations (Continued)
Lakkis et al.
2011 [33]
Oral hygiene instructions,
SRP
n.r.;
n.r.
n.r.
Suvan et al.
2014 [34]
Oral hygiene instructions,
full-mouth mechanical periodontal
debridement with hand and ultrasonic
instruments performed with local
anesthesia by the same clinician
Within a 24-h period of time;
n.r.
No individuals in the sample had missing
data for any of the covariates listed in this
study.
CHX chlorhexidine, min minute, mm millimeter, n.r. not reported, PD pocket depth, SRP scaling and root planing
Fig. 1 PRISMA 2009 flow diagram
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Limitations
Some patients could not be reviewed or discontinued
the study for personal reasons [28, 29, 31]. Weight loss
and pregnancy were additional reasons to be excluded in
the study of Duzagac et al. [29] (Table 7).
The quality of the included studies was evaluated
through the Newcastle-Ottawa Quality Assessment Scale
(Table 8).
Discussion
This review focused on obesity and the outcome after
non-surgical periodontal therapy and has shown that
currently there is no really robust scientific evidence to
reach solid conclusions and recommendations.
Three papers [8, 29, 30] were found, which did not
find any statistically significant negative impact of obes-
ity on the response to non-surgical periodontal therapy,
whereas five papers [28, 31–34] showed the opposite, i.e.
a clearly negative influence of obesity on the treatment
outcomes.
With regard to the quality of evidence, seven included
papers [8, 28, 29, 31–34] reported some limitations.
Al-Zahrani et al. [8] included only women. Gonçalves
and co-workers [31] did not consistently apply the ac-
cepted definitions of overweight and obesity, but rather
included the waist-to-hip-ratio (WHR) for their defini-
tions, probably leading to inclusion of patients with a
BMI inferior to 30 kg/m2 into the obesity group. Thus
Table 8 Newcastle – Ottawa Quality Assessment Scale
Stars represent “awards” for each quality item and serve as a quick visual assessment. A maximum of one ‘star’ for each item within the ‘Selection’/‘Exposure’
categories and a maximum of two ‘stars’ for ‘Comparability’ can be awarded
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the results are difficult to interpret and compare with
the other studies and are therefore not applicable for
patients with a BMI ≥40 kg/m2 [31]. Nonetheless, these
studies still show a clearly better tendency with regard
to the treatment response for patients without obesity
as defined in their study. Lakkis et al. [33] chose an-
other interesting way to find an impact of obesity on
the outcome of non-surgical periodontal treatment.
They compared obese people who had undergone bar-
iatric surgery (BS) with obese who did not. After weight
loss in the BS group, a reduction in total adipocytes
might have resulted in a decrease in adipokines and
pro-inflammatory mediators released by those adipose
cells. This systemic inflammatory reduction might have
played a role in reducing the insulin resistance resulting in
a better outcome after periodontal therapy as suggested by
the authors [33]. Some limitations in the specific profile of
the obese patients (nondiabetic, non-smoker) in the paper
of Bouaziz et al. (28) may restrict the extrapolation of the
results to the whole obese population. Furthermore, the
small sample size may also limit the power of this study.
Duzagac et al. [29] failed to include a control group of
periodontally healthy controls with obesity. Additionally
the mean periodontitis parameters were within the limits
of “moderate” periodontitis, and the WHR and BMI values
of these obese patients were predominantly below those
characterizing morbid obesity. So, the results of this study
may not be extrapolated to those with severe periodontitis
or morbid obesity. The second included study of Gon-
çalves and co-workers [32] assumes that the high inter-
patient variance in adipokine levels may reduce the statis-
tical power to detect treatment effects, as previously re-
ported. The results presented by Suvan et al. [34] may
have been influenced by study limitations linked with un-
equal numbers in BMI categories and sample size. In
addition, there may have been limitations with regard to
the interpretation associated with the post hoc secondary
analysis experimental design, although variation in clinical
assessment and treatment was minimized by examiner
and treatment clinician stability. This study did not consti-
tute a higher level of evidence in the context of evidence-
based health care levels of scientific evidence [34].
Overall, obesity is an obvious, visible stigma so that
the studies cannot be considered blinded. This may be
another possible bias in each of the studies.
Five studies [8, 28, 29, 31, 32] excluded smokers. Since
smoking influences periodontal health these studies are
biased [9] and may not be fully representative for the
typical overall population. Overall it appears, however,
that a positive effect of normal weight is present in non-
smokers [28, 31, 32] and in smokers [34].
As mentioned before, the included studies differed in
statistical methods, populations, sample sizes, definition
of chronic periodontitis, definition of obesity, time of
outcome measurement, smoking status, periodontal as-
sessment and non-surgical periodontal therapy. Therefore,
it was not only impossible to perform a meta-analysis but
also draw clear conclusions.
Nonetheless there is a consensus in the studies that obes-
ity is associated with different baseline PPD levels. The
large cohort in the study of Suvan et al. [34] and the long
term results of Gonçalves et al. [31, 32] may lead to the
conclusion that obesity is an important negative factor
which influences non-surgical periodontal therapy.
In summary, all studies [8, 28, 29, 31–34] included in
this review validated the efficacy of non-surgical periodon-
tal therapy, except the study of Eldin and co-workers [30]
who did not report any efficacy of the therapy (Table 3).
Clinically, it appears obvious that a therapy is necessary to
reach periodontal health independent of the patient’s body
mass index.
Because this systematic review provided only moderate
evidence that obesity is an important factor for non-
surgical periodontal therapy, future prospective cohort
studies are needed to confirm these findings [36]. Such
trials should be of high methodological quality. They
should control important confounding factors such as
smoking status, severity of chronic periodontitis, severity
of obesity. Every patient should get the same periodontal
treatment and periodontal maintenance. Overall, there is
a possibility to solve the research question even though
blinding of the examiners to obesity or non-obesity sta-
tus is not practically possible.
Clinicians should know that obesity may have some in-
fluence on periodontal status and are likely to have a
negative impact on the clinical outcome of conservative
treatment, even if this systematic review found only five
[28, 31–34] out of eight papers [8, 28–34] corroborating
the influence of obesity on the clinical periodontal out-
come focusing on PPD as surrogate parameter for peri-
odontal healing.
Clinicians might consider a weight reduction diet as
an additional treatment for periodontal health with a
positive effect expected after 6 and 12 months [31, 32].
Also it should not be neglected that weight control has
substantial other beneficial health effects which on their
own justify such a recommendation.
Conclusion
This systematic review indicates a possible negative rela-
tionship between obesity and poorer treatment outcome
in obese patients after non-surgical therapy based on the
results of five out of eight studies. Three of these studies
denied an impact of obesity on the treatment. The po-
tentially inferior healing response could be based on
pathophysiological inflammatory models.
Baseline levels showed also a poorer periodontal health
in patients with obesity compared with non-obese patients.
Gerber et al. BMC Oral Health  (2016) 16:90 Page 15 of 20
No study found any better dental health parameters in
obese than in non-obese individuals, and although dental
health may not be the most important target for arriving
at a near normal body weight, a person who can keep
his or her body weight near normal might, in addition to
all other established health benefits, count on having
better periodontal health than if they are obese.
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